Item
Panax Ginseng 14 % (Panax Ginseng 14%)
White Ginseng Extract 14.0% Ginsenosides HPLC
Natural Flavor Ingredient
Attributes
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| Huisong Pharmaceuticals | Please fill in ?, N/A ? CHN |
| Nutrisan Biotech | Room 1018 Building 1, Zheshang International Center, 355 Jichang Road, Hangzhou, Hangzhou N/A CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Huisong Pharmaceuticals | Allergens.pdf | 6/11/2019 | 6/10/2021 |
| Allergens | Nutrisan Biotech | Allergens.pdf | 11/11/2020 | 11/11/2022 |
| CoA Sample | Nutrisan Biotech | COA - Panax Ginseng Extract 140 - 25022020.pdf | 2/25/2020 | 2/24/2022 |
| Ingredient Statement | Nutrisan Biotech | Composition statement - Panax Ginseng Extract 140 HPLC.pdf | 11/3/2020 | 11/3/2021 |
| Country of Origin | Huisong Pharmaceuticals | Country of Origin.pdf | 6/11/2019 | 6/10/2022 |
| Country of Origin | Nutrisan Biotech | Country of Origin.pdf | 11/3/2020 | 11/3/2023 |
| EtO Statement | Nutrisan Biotech | Ethylene Oxide Statement - Panax Ginseng Extract 140 HPLC - 08032021.pdf | 3/8/2021 | 3/8/2023 |
| EtO Statement | Huisong Pharmaceuticals | ETO Statement - Panax Ginsend Extract PG104 ex Huisong - 15092020.pdf | 9/15/2020 | 9/15/2022 |
| GRAS/NDI/ODI Statement | Nutrisan Biotech | FOODGR~1.PDF | 9/24/2020 | 9/24/2023 |
| HARPC Food Safety Plan (Item) | Nutrisan Biotech | Manufacturing Process with CCP - Panax Ginseng Extract 140 HPLC - 20012020.pdf | 1/20/2020 | 1/19/2023 |
| Safety Data Sheet (SDS) | Nutrisan Biotech | MSDS - Panax Ginseng Extract 140 HPLC.pdf | 11/20/2019 | 11/19/2021 |
| GMO | Nutrisan Biotech | Non GMO Statement - Panax Ginseng Extract 140- 20112019.pdf | 11/20/2019 | 11/19/2021 |
| Irradiation Status Statement | Nutrisan Biotech | Non-Irradiation Statement - Panax Ginseng Extract 140 - 20112019.pdf | 11/20/2019 | 11/19/2021 |
| Irradiation Status Statement | Huisong Pharmaceuticals | Non-Irradiation Statement PG104.pdf | 1/31/2020 | 1/30/2022 |
| GRAS/NDI/ODI Statement | Huisong Pharmaceuticals | NotApplicable_GRASNDIODIStatement.pdf | 12/14/2023 | 12/13/2026 |
| Ingredient Statement | Huisong Pharmaceuticals | NotApplicable_IngredientStatement.pdf | 2/8/2021 | 2/8/2022 |
| No Animal Ingredient Statement | Huisong Pharmaceuticals | NotApplicable_NoAnimalIngredientStatement.pdf | 2/8/2021 | 2/8/2022 |
| No Animal Ingredient Statement | Nutrisan Biotech | NotApplicable_NoAnimalIngredientStatement.pdf | 11/23/2020 | 11/23/2021 |
| Residual Statement | Huisong Pharmaceuticals | NotApplicable_ResidualStatement.pdf | 2/8/2021 | 2/8/2022 |
| Residual Statement | Nutrisan Biotech | NotApplicable_ResidualStatement.pdf | 11/23/2020 | 11/23/2021 |
| Shelf Life | Nutrisan Biotech | NotApplicable_ShelfLife.pdf | 11/5/2020 | 11/5/2022 |
| WADA/NSF/NFL Statement | Huisong Pharmaceuticals | NotApplicable_WADANSFNFLStatement.pdf | 1/11/2023 | 1/10/2025 |
| California Prop. 65 | Nutrisan Biotech | Prop 65 Statement - Panax Ginseng Extract 140 HPLC -08032021.pdf | 3/8/2021 | 3/8/2023 |
| California Prop. 65 | Huisong Pharmaceuticals | Prop 65 Statement-PG104.pdf | 1/31/2020 | 1/30/2022 |
| Product Specification Sheet | Nutrisan Biotech | Spec - Panax Ginseng Extract 140 HPLC.pdf | 10/10/2018 | 10/9/2021 |
| Shelf Life | Huisong Pharmaceuticals | Specification-PG104 updated.pdf | 1/31/2020 | 1/30/2023 |
| CoA Sample | Huisong Pharmaceuticals | Typical CoA Panax Ginseng Extract (PG110W) ex. Huisong 12.06.2018.pdf | 6/11/2019 | 6/10/2021 |
| WADA/NSF/NFL Statement | Nutrisan Biotech | WADA Statement 2022 - Panax Ginseng Extract 14% (PG104) ex Huisong - 30.03.2022.pdf | 3/30/2022 | 3/29/2024 |
